Skip to main content
Clinical Trials/NL-OMON52529
NL-OMON52529RecruitingNot Applicable

Focused Ultrasound and Radiotherapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastases - FURTHER

niversitair Medisch Centrum Utrecht0 sites65 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
65

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Age >= 18 years
  • Patient capable of giving informed consent
  • Painful metastatic bone lesion (NRS >= 2)
  • Patient-localised pain with a distinct pathological substrate on recent CT/MRI
  • Target lesion location is >75% accessible for MR-HIFU
  • Participant able to fit in the MRI gantry
  • Reasonable performance score (KPS > 50% or Zubrod/ECOG/WHO < 3)
  • Life expectancy > 3 months

Exclusion Criteria

  • Need for surgery of targeted location due to (impending) pathological fracture
  • Unavoidable critical structures or dense tissues in target area *
  • Contra indications MRI or sedation/anaesthesia
  • Participant enrolled in another clinical interventional study related to bone
  • metastases treatment or pain relief treatment
  • Clinically relevant medical history or physical findings that could interfere
  • with the patient's safety as judged by the treating physician

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials